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INTRODUCTION 
Glaucoma is a blinding cause of optic neuropathy, chronic in 
nature, progressive disease, characterized by increased intraocular 
pressure which is the treatable one, optic nerve head changes and 
corresponding visual field defects in automated perimetry. It occurs due 
to retinal ganglion cell death. It is also associated with retinal nerve fibre 
layer defects, disc hemorrhages and peripapillary atrophy. 
AQUEOUS HUMOR DYNAMICS: 
Aqueous humor is a colorless fluid secreted from ciliary process 
into the posterior chamber, passes via pupil, enters the anterior chamber. 
CILIARY PROCESS: 
These are finger like projections projecting from pars plicata. 
They are 70 in number. The ultra-structure consists of   
 central capillaries which has fenestrated endothelium, 
 stromal part, 
 two layered epithelium, both layers are connected with each 
other by apical apposition1. 
 
 
 
 
 
 
 
 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the anterior chamber it is drained via two pathways namely, 
1.Trabecular pathway 
2. Uveoscleral pathway. 
 
Figure 1 : Ciliary process 
Figure 2 : Anatomical layers of ciliary process 
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1. TRABECULAR OUTFLOW: 
It is the main outlet pathway, 80%-90% of aqueous humor is 
draining out by this pathway. Through the trabecular meshwork it 
enters schlemm’s canal, and drained into collector channels and 
episcleral veins. 
2. UVEOSCLERL OUTFLOW: 
Through this pathway, 10%-20% fluid is drained out into 
suprachoroidal space and drained by venous circulation of ciliary body 
and sclera.  
Amount of secretion is 2.5 microlitres/min.  
 
STEPS OF AQUEOUS FORMATION: 
3 processes are involved namely, 
1.Diffusion – it accounts for 10% of aqueous formation. 
2.Ultra filtration- it accounts for 20% of aqueous formation. 
3.Secretion- major part, 70% of aqueous is produced by this 
process. 
1. Diffusion: 
 
This process transports lipid soluble substances via lipid soluble 
membrane. This process is proportional to concentration gradient. 
2. Ultrafiltration: 
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This process transports water soluble substances via micro pores 
in the cell membrane. This process is controlled by hydrostatic pressure, 
which is dependant on IOP, 
Blood pressure in ciliary capillaries 
Plasma oncotic pressure. 
The above two mechanisms are passive processes. 
3. Secretion: 
As it is an active process, it requires energy. Large size water 
soluble molecules are transported by this process. It plays major part in 
aqueous secretion. 
Total volume of aqueous fluid is 0.3 ml out of which 
0.25ml is in anterior chamber 
0.05 ml is in posterior chamber. 
Refractive index 1.336. 
The density of aqueous is slightly greater than water. 
PH is 7.2. It is slightly hyperosmotic than plasma. 
  CONTENTS OF AQUEOUS: 
• Water forms 98-99% 
• Glucose – It is 70% of that in plasma. It nourishes cornea. Its 
concentration is increased in diabetics. 
• Protein – it is lesser than that in plasma. 
• Immunoglobulins- IgG is normally present in aqueous. 
  ORGANIC IONS: 
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• Ascorbate – It is 10 times higher than plasma, functions as 
antioxidant, 
•  Lactate. 
INORGANIC IONS: 
• Sodium, Potassium, 
•  Bicarbonate ions,  
• Chloride ions, 
• Calcium,  
• Phosphate2 
ANATOMY OF ANGLE STRUCTUTRES: 
      Angle recess is formed between posterior surface of cornea and 
anterior surface of iris bounded from anterior to posterior by 
 Schwalbe’s line, 
 Trabecular meshwork, 
 Scleral spur, 
 Anterior surface of Ciliary body along with root of iris. 
   1.Schwalbe ‘s Line: 
It is the posterior termination of descemet’s membrane. 
   2.Trabecular Meshwork: 
   It consists of 3 parts,  
uveal meshwork is the innermost,  
corneoscleral meshwork is the intermediate layer,  
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juxtacanalicular tissue is the outer one adjacent to schlemm’s 
canal. Juxta canalicular tissue offers maximum resistance to 
aqueous outflow. 
3.Scleral Spur: 
It is the thin lip of scleral projection which gives attachment to 
ciliary muscle. It accommodates schlemm’s canal. Posteriorly it gives 
attachment to longitudinal ciliary muscle. 
  4.Ciliary Body Band: 
 Is a greyish band,width depends on the level of iris 
insertion. It can be wider in myopes. It has 2 parts. 
 Anterior pars plicata 
 Posterior pars plana. 
The outermost part is supra ciliary stroma and inner part is 
stroma which has ciliary muscle as the major component. The ciliary 
muscle fibres are Longitudinal fibres , Circular fibres and Radial fibres. 
Nerve supply: 
Ciliary ganglion supplies parasympathetic nerve supply to the 
Ciliarybody. 
Vascular supply: 
It is by major arterial circle. This circle is formed by the 
anastomosis of long and short posterior ciliary arteries 
  
 
 
7 
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Figure 3 : Aqueous outflow pathway 
Figure 4 : Anatomy of trabecular meshwork 
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PIGMENTED AND NONPIGMENTED EPITHELIAL LAYER: 
Pigmented layer is continued with retinal pigment epithelial 
layer. Nonpigmented layer is continued with pigment epithelial layer of 
iris. 
SCHLEMM'S CANAL: 
        It is an endothelium lined channel. 
COLLECTOR CHANNELS: 
         2 types are there. 
• INDIRECT CHANNELS, 
• DIRECT CHANNELS. 
These channels drain into episcleral veins. 
These episcleral veins drain into cavernous sinus via 
Anterior ciliary veins and  
Superior ophthalmic veins. 
INTRAOCULAR PRESSURE: 
Intraocular pressure is determined by aqueous production, 
resistance to aqueous outflow and episcleral venous pressure. 
The circulation of aqueous maintains the Intraocular pressure. 
The distribution of intraocular pressure in our population is 11 to 21 
mmhg. It can be measured by tonometry. Various types of tonometry are 
available to measure intraocular pressure. Intraocular pressure shows 
diurnal fluctuation.  
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Normally there is early morning peak and evening trough. 
Normal difference will be 6 mmhg. Patients with high diurnal 
fluctuation will have more progression of glaucoma. No sex difference 
found in the distribution of intraocular pressure3.   
 
FACTORS AFFECTING INTRAOCULAR PRESSURE: 
1.AQUEOUS HUMOR PRODUCTION: 
It is controlled by infection and inflammation of ciliary body, 
blood pressure and osmolarity of plasma. Beta blockers and carbonic 
anhydrase inhibitors have influence on intraocular pressure by affecting 
aqueous production. 
2. AQUEOUS OUTFLOW RESISTANCE: 
It is influenced by trabecular meshwork inflammation, clogging 
of trabecular mesh by inflammatory and cellular debris, exudates, 
pigments, tumor cells.Also pupillary block and peripheral anterior 
synechiae offers resistance to outflow. Outflow resistance is decreased 
by prostaglandins, miotics and adrenaline. 
3. EPISCLERAL VENOUS PRESSURE: 
Normal amount of episcleral venous pressure is 8 -10 mmhg. It is 
raised in sturge weber syndrome, where the glaucoma is refractory to 
routine medical management. It is raised also in thyroid orbitopathy, 
caroticocavernous fistula. Valsalva maneuver can also increase the 
episcleral venous pressure. 
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TONOMETRY: 
It is the procedure used to measure intraocular pressure. 
It can be  
 Contact  
 Noncontact tonometer. 
 In contact tonometer type, there are 2 varieties. 
1. Indentation tonometer - schiotz, 
2. Applanation tonometer which can be categorized into  
a. VARIABLE FORCE AND CONSTANT AREA: 
 It comprises, 
 Goldmann Applanation tonometer,  
 Perkins,  
 tonopen, 
 pneumotonometer 
b. CONSTANT FORCE AND VARIABLE AREA: 
 Makalakov 
NON-CONTACT TONOMETER:  
 Pulse air 
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Figure 5 : Schiotz tonometer 
Figure 6 : Goldmann Applanation tonometry 
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NEWER ADVANCES: 
Trans palpebral tonometer, 
Dynamic contour tonometry. 
Sensimed trigger fish. 
Schiotz and Maklakov displace large amount of fluid,thereby 
raising the intraocular pressure significantly, so they are called high 
displacement type,these are less accurate than the low displacement one. 
 But Goldmann and Mackay marg displace only very small amount of 
aqueous, so they are called low displacement tonometry type. Goldmann 
tonometer pushes only 0.5 microliter, so it increases only 3% increase in 
Intraocular pressure2. 
MECHANISM OF INDENTATION TONOMETER: 
When the indentation tonometer is placed on cornea, additional 
forces are set up by outer coats of eye ball, so true intraocularpressure 
(p0) is further raised to P1.Therefore true IOP is derived from 
Fridenwald conversion table. The major demerit is false recordings were 
observed in patients with abnormal scleral rigidity 
MECHANISM OF APPLANATION TONOMETRY 
They measure intraocular pressure based on Imbert-Fick Law. 
Corneal rigidity and capillary attraction of tear meniscus forces 
influence IOP. If the area flattened is 3.06 mm2, the above forces cancel 
them each other. 
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Among the applanation tonometers, Goldmann applanation is the 
gold standard tonometry. It contains biprism mounted on slitlamp 
measured with cobalt blue filter. Measurement is influenced by corneal 
thickness and astigmatism. 
GONIOSCOPY: 
The term GONIOSCOPY was termed by Trantas. It is the 
procedure to look for the angle status whether it is open or closed and to 
look for the presence of peripheral anterior synechiae, foreign body in 
the angle, blood in the angle. 
Based on the angle status we can classify the glaucoma patients into 
• Open angle glaucoma, 
• Angle closure glaucoma, 
• Occludable angles. 
It has to be done for angle closure and occludable angles 
periodically. 
Basic principle of this procedure is, the total internal reflection of 
light rays from the angle is eliminated with the help of gonioscope. 
There are two types. 
1.Direct Gonioscope   
2.Indirect Gonioscope 
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Figure 7 : Mechanism of gonioscopy 
Figure 8 : Gonioscopic view of Angle Structures 
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  1. DIRECT GONIOSCOPY: 
• It is used with operating microscope. 
• Koeppe lens – most commonly used lens, for diagnostic purpose. 
• Swan jacob goniolens – also used for surgical purpose for 
children. 
•  Richardson shaffer's lens – small koeppe lens used for infants. 
•  Huskin's barkan lens – prototype of surgical goniolens. 
•  Worth goniolens -  anchors to cornea with partial vaccum. 
BENEFITS OF DIRECT GONIOSCOPY: 
It provides a straight view in contrast to inverted view with 
indirect lens. 
We can do a detailed examination of angle structures. 
 By using two lenses, we can examine both eyes simultaneously. 
 Panoramic view is obtained so that one part of angle can be 
compared with the other part. 
 Flexibility is good. 
 It can be used in goniotomy surgery. 
    
DISADVANTAGES:          
1) It is inconvenient to use and also time consuming. 
2) Added benefits of slitlamp was not available. 
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Figure 9 : Koeppe Lens, 
examination with koeppe lens 
Figure 10: Swan Jacob lens, 
examination with swan Jacob lens 
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INDIRECT GONIOSCOPY: 
• Goldmann three mirror gonioprism: 
Mirror inclined at 59° - used for gonioscopy, 
                   67º – for examining pars plana of ciliary body, 
                   73º -  to look for ora serrata. 
• Goldmann two mirror gonioprism: 
                    Mirror inclined at 62º 
• Goldmann single mirror prism: 
                       Mirror inclined at 64º 
• Allen thorpe gonioprism: 
It has four prism instead of mirrors. we can see the whole 
angle without rotating the prism. 
Above lenses will require coupling agent. 
GONIOLENS NOT REQUIRING COUPLING AGENT: 
• Zeiss four mirror – Mirrors inclined at 64º, indentation 
gonioscopy can be done. 
•  Posner -  It has detachable handle 
•  Sussman- It has no handle. 
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Figure 11 : Goldmann  single and 
three mirrorgoniolens 
Figure 12 : Sussman four 
mirror lens 
Figure 13 : Zeiss four mirror lens 
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FUNDUS CHANGES IN GLAUCOMA: 
Normal optic disc is vertically oval, 1.5 mm in diameter. Neuro 
retinalrim lies between disc margin and cup. Normally it will be pink in 
color. It follows ISNT rule. That implies that inferior neuro retinal rim is 
the broadest. The next one is superior, nasal and temporal neuro retinal 
rim. As glaucoma advances, neuro retinal rim will be thinned out and 
lost. Cup represents absence of axons. Pallor of cup indicates loss of 
glial support. 
CUP DISC RATIO: 
It is expressed as diameter of the cup as a fraction of diameter of 
optic disc. vertical cup disc ratio is more important than horizontal cup 
disc ratio,because pores are larger in superior and inferior poles and also 
less glial support to superior and inferior pole areas.  
Cup disc ratio of > 0.3 or Asymmetry of cup disc ratio >0.2 between two 
eyes are considered significant.  
Disc size is also important while measuring cup disc ratio. 
OPTIC NERVE HEAD CHANGES IN GLAUCOMA: 
NOTCHING: 
Focal loss of neuroretinal rim results in notching, most common in 
inferotemporal quadrant,which is more specific of glaucoma 
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BAYONETTING:   
It means double angulation of a blood vessel. As neuroretinal rim 
thins out, blood vessel crossing the rim will double angulate resulting in 
bayonetting. 
LAMINOR DOT SIGN:   
It occurs due to enlargement of fenestrae in lamina cribrosa. 
It appears as greyish dots. 
TEMPORAL UNFOLDING: 
When loss of neuroretinal rim starts temporally, proceeds 
circumferentially, it is called as temporal unfolding with concentric 
atrophy. 
BEAN POT CUPPING: 
Advanced cupping with total loss of neuroretinal rim results in bean 
pot cupping. 
SPLINTER HEMORRHAGES: 
Hemorrhage which crosses disc margin mostly seen in 
inferotemporal quadrant It signifies the progression of the disease, most 
commonly seen in normotensive glaucoma. It is also called Drance 
hemorrhages. 
BARRING OF CIRCUMLINEAR VESSEL: 
As the neuroretinal rim recedes, normal circumlinear vessel 
which outlines the cup will be barred from cup margin. 
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VERTICAL ECCENTRICITY OF CENTRAL RETINAL VESSEL 
TRUNK 
RETINAL NERVE FIBRE LAYER 
Retinal nerve fibre layer will be seen as striations in light reflex. On 
red free filter, retinal nerve fibre layer defects can be visualized as 
darker areas of slit or wedgeshaped defects. 
PERIPAPILLARY PIGMENTATION: 
There are 2 zones, alpha and beta zones. 
Beta zone lies between outer alpha and optic disc margin. It 
occurs due to retraction of retinal pigment epithelial layer due to atrophy 
and choroidal degeneration. Zone beta corresponds with visual field 
defects. 
Zone alpha is the outer zone,which lies external to beta zone. It 
occurs due to retinal pigment epithelial hyper or hypo pigmentation6. 
 OPTIC DISC EVALUATION: 
It can be done with direct ophthalmoscopy, indirect 
ophthalmoscopy, slit lamp biomicroscopy with 90 d or 78 d lens, fundus 
camera photography. It can be measured quantitatively by confocal 
scanning laser tomography, also known as Hiedelberg retinal 
tomography, scanning laser polarimetry, optical coherence tomography. 
With every follow up, following findings should be noted. 
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1. Optic disc size and shape 
2. Optic cup size and shape 
3. Neuroretinal rim 
4. Disc hemorrhages 
5. Blood vessel changes 
6. Peripapillary changes 
7. Retinal nerve fibre layer changes. 
  
Figure 14 : Glaucomatous changes of optic disc 
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ASSESSMENT OF GLAUCOMA PATIENT: 
Glaucoma assessment starts with History taking. Proper history 
taking is very important in diagnosing glaucoma early. Any family 
history of glaucoma in the family members should arouse suspicion. 
Any history of frequent change of presbyopic glasses, colored halos 
around light, headache, delayed dark adaptation and any chronic usage 
of topical drops, topical medications needs further investigation. 
 Screening of the population includes, 
 IOP examination, 
 Fundus examination,  
 Visual field testing by supra threshold strategies. 
CLASSIFICATION OF GLAUCOMA: 
It has been classified as 
• primary congenital glaucoma which is present since birth and 
there are not accompanied with any systemic and ocular disease. 
• Developmental glaucoma is termed when the glaucoma is 
associated with ocular and systemic diseases. 
• Juvenile glaucoma is termed when glaucoma occurs after 3 years 
of age. 
Primary congenital glaucoma occurs due to involvement of CYP1B1 
gene. Juvenile glaucoma is associated with mutation of TIGR. 
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Primary congenital glaucoma is characterized by blepharospasm, 
watering,pain. On examination corneal diameter is increased with 
corneal edema, haab's striae due to breaks in decemat's membrane. 
Gonioscopy shows anterior insertion of iris. IOP is characteristically 
elevated. Due to stretching and enlargement, axial length will be 
increased resulting in axial myopia, zonular dialysis, eventually 
subluxation of lens. Due to axial myopia, the child will go for 
amblyopia. Decemat's membrane break can cause astigmatism. Patient is 
managed initially with IOP lowering drugs. But surgery is the mainstay 
of treatment. Goniotomy can be done if the cornea is clear. 
Trabeculotomy is planned if there is corneal edema.Trabeculotomy can 
be combined with trabeculectomy. 
SYNDROMES AND GLAUCOMA: 
 Sturge weber syndrome, 
  Microspherophakia,   
 Pierre robinson syndrome, 
 Lowe's syndrome, 
 Homocystinuria, 
 Marfan's syndrome, 
 Neurofibromatosis, 
 Aniridia, 
 Peters anomaly2. 
Primary glaucoma can be either primary open angle glaucoma and 
primary angle closure glaucoma. 
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Open angle glaucoma could be primary open glaucoma, normal 
tensive glaucoma, and ocular hypertension.  
Secondary open angle glaucoma can be classified as, 
• Pseudo exfoliation glaucoma, 
•  Pigmentary glaucoma, 
• Uveitic glaucoma, 
•  Intra ocular tumors causing glaucoma, 
• Intra ocular hemorrhage causing glaucoma, 
• Lens induced glaucoma 
• Traumatic glaucoma, 
• Steroid induced glaucoma, 
• Retinal detachment associated glaucoma. 
  Secondary angle closure glaucoma could be classified as 
• Anterior pulling mechanism due to, 
ICE syndrome, 
Fibrous ingrowth, epithelial down growth. 
• Posterior pushing mechanism due to, 
Ciliary body cysts and tumors, 
Choroidal effusion and detachment, 
• Secondary glaucoma with pupillary bock, 
• Aqueous misdirection syndrome 
• Lens induced glaucoma. 
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PATHOGENESIS OF GLAUCOMA: 
Pathogenesis of glaucoma could be either due to mechanical or 
vascular etiology. 
MECHANICAL DAMAGE: 
            It is due to chronic increased IOP causing direct damage, or 
impaired  delivery of nutrients or neurogenic factors. 
VASCULAR DAMAGE: 
            It can be due to impairment of auto regulation. Vascular factors 
like Nitric oxide and endothelin also play role. NTG is more common in 
patients with ischemic and vasospastic disease. 
          There can be genetically determined apoptosis- programmed cell 
death. 
          Glutamate induced NMDA receptor activation. 
SYSTEMIC FACTORS ASSOCIATED WITH GLAUCOMA: 
• Diabetes 
•  Hypertension, 
• Migraine, 
• Grave's disease 
• Cushing's syndrome. 
OCULAR FACTORS ASSOCIATED WITH GLAUCOMA: 
• Myopia, 
• CRVO 
•  central corneal thickness2. 
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SYMPTOMS AND SIGNS OF GLAUCOMA: 
            In the early stage, there won't be any symptoms. 
Gradually there can be 
• Mild pain, 
• Headache, 
• Colored halos around the light, 
• Delayed dark adaptation, 
• Peripheral constriction of fields. 
 SIGNS OF GLAUCOMA: 
In POAG, slit lamp examination of anterior segment will be 
normal. Gonioscopy will show open angles. 
          IOP will be elevated. 
VISUAL FIELD DEFECTS IN GLAUCOMA: 
Standard automated perimetry is done by Humphery field 
analyzer or Octopus. 
Programs used are, 
• 30-2, 
• 24-2, 
• 10-2, 
• Macular program, 
• Nasal step program. 
In 30-2, total points tested are 76 points in 30degree field, 6degrees 
apart. 
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In 24-2, total points tested are 54 in 24degree field, 6degrees apart. 
In 10-2 total points tested are 68 points in 10degree field, 2degrees 
apart. 
In Macular program, 16 points are tested in central 5degree, 2 
degrees apart. 
FIXATION TARGET: 
• Central small diamond. 
• Large diamond and 
• Bottom LED are used for patients with central scotoma. 
TARGET SIZE: 
Goldman size 3 and 5 
TESTING STRATERGY: 
OCTOPUS: 
         3 strategies are, 
• Normal 
•  Dynamic 
• TOP- It is tendency oriented perimetry. 
HUMPHERY FIELD ANALYSER: 
It has three strategies 
• SITA- it is swedish interactive threshold algorithm. 
• SITA FAST 
• FULL THRESHHOLD. 
RELIABILITY FACTORS: 
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• Fixation loss should be less than 20%, 
•  False positive should be less than 33%. 
• Similarly false negative should be less than 33% 
 Visual field printout will be showing 
• Patient data and refraction 
• Test parameters and test programs, strategies 
• Grey scale 
• Value table 
• Corrected data and corrected comparison data 
• Probability plot and corrected probability plot 
• Bebis curve 
• Global indices 
 In Octopus, it includes 
• Mean sensitivity, 
• Mean defect, 
• Loss variance, 
• Short term fluctuation, 
• Corrected loss variance. 
In Humphery, 
• Glaucoma hemifield test, 
• Mean deviation, 
• Patterned standard deviation, 
• Corrected patterned standard deviation, 
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• Short term fluctuation. 
FIELD DEFECTS: 
• Isolated para central scotoma is the early defect. 
• It can evolve into arcuate scotoma, 
• Bi arcuate scotoma. 
• Ring scotoma   
• Nasal step defect. 
• Advanced field defects sparing temporal island of vision can be 
seen in end stage. 
PREPERIMETRIC GLAUCOMA: 
        Normally visual field defects appear when there is 20-40% loss of 
retinal ganglion cell death occurs. So early detection of retinal nerve 
fibre layer loss diagnoses glaucoma at early stage12. 
RECENT ADVANCES IN PERIMETRY: 
• Short wavelength automated perimetry- 
It is also known as SWAP, Blue on yellow perimetry. By 
this method, we can detect glaucoma early than standard 
automated perimetry. 
 High pass resolution perimetry:   
It is also known as ring Perimetry, it uses rings instead of 
spots. 
• Flicker perimetry: 
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The stimulus in this perimetry is flickering stimulus 
instead of static flashes used in other types. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 : Octopus perimetry of a patient showing bi-arcuate field defects 
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MANAGEMENT: 
     It includes 
• Medical management, 
• Laser treatment, 
• Surgical management. 
  MEDICAL MANAGEMENT: 
   It acts by 
• Suppressing aqueous production, 
• Increasing outflow, 
• Neuro protective drugs. 
CLASSIFICATION OF ANTIGLAUCOMA DRUGS: 
   It is classified as 
• B – blockers, 
• Adrenergic agonists, 
• Prostaglandin analogue, 
• Carbonic anhydrase inhibitors 
• Hyper osmotic agents, 
• Miotics. 
SYMPATHOMIMETIC DRUGS: 
It includes, 
1.EPINEPHRINE: 
It acts on both alpha and beta receptors. 
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2.DIPIVEFRINE: 
It is a prodrug, which is converted to epinephrine which 
acts on alpha and beta receptors. 
3.CLONIDINE: 
It is a centrally acting antihypertensive agent. In glaucoma 
it acts by decreasing aqueous humor production by acting on 
alpha receptors. 
4.BRIMONIDINE (0.2%) 
It is a selective alpha 2 adrenergic agonist. This drug has 
triple action. 
• It decreases aqueous production, 
• It increases aqueous outflow also, 
• It has neuro protective action. 
  5.APRACLONIDINE: 
It is used after laser procedures to prevent post IOP spike 
following, 
 Laser trabeculoplasty, 
 YAG laser iridotomy, 
 YAG capsulotomy. 
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BETA ADRENERGIC BLOCKERS: 
It includes, 
1.TIMOLOL: 
It is the most commonly used drug. First choice drug in POAG 
unless contraindicated. It is the nonselective beta blocker. It decreases 
aqueous secretion by blocking beta 2 receptors in ciliary body. 
2.LEVOBUNOLOL: 
It is also a nonselective beta blocker similar to timolol. 
3.BETAXOLOL: 
It is a cardio selective beta 1 blocker, thereby safely used in 
Bronchial asthma patients. It is most commonly used in congenital 
glaucoma. 
4.CARTEOLOL 
5.METIPRANOLOL 
Beta blockers are contraindicated in bradycardia, heart failure, 
arrythmias, Respiratory diseases like bronchospasm, obstructive airway 
disease. 
CARBONIC ANHYDRASSE INHIBITORS: 
It includes, 
   1. ACETAZOLAMIDE 
   2. METHAZOLAMIDE, 
   3. DORZOLAMIDE, 
   4. BRINZOLAMIDE. 
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These drugs inhibit carbonic anhydrase enzyme which is essential 
for aqueous humor production. But these drugs can cause electrolyte 
imbalance, gastric ulcer, urinary disturbance. Acetazolamide is available 
as tablets. It is available in 250 mg strength. 
HYPEROSMOIC AGENTS: 
1.GLYCEROL: 
This oral hyperosmotic agent is available in 50% solution. 
Dosage can be 1 gm/kg body weight. Usually it is given as a mixture 
with lemon juice or water. But it is contraindicated in diabetic patients 
with glaucoma. 
2.MANNITOL: 
It is an intravenous drug, used in very high intraocular pressure 
and acute angle closure attack. Dosage is 1gm /kg body weight. It is 
available in 20% solution. It can be given safely in diabetic patients. But 
caution required in patients with cardiac and pulmonary edema patients, 
as it can precipitate pulmonary edema. 
PROSTAGLANDIN ANALOGUES: 
1. LATANOPROST: 
It is available in 0.005%. It acts by increasing uveoscleral outlet, 
thereby reducing intraocular pressure. 
2. BIMATOPROST: 
It is available in 0.03% 
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3. TRAVOPROST: 
It is available in 0.004% 
4. UNOPROSTONE: 
It is available in 0.12%. It is PG F2 alpha. 
Prostaglandin analogues increases uveoscleral outflow. Because 
of long duration of action, it can be given as once daily dosage. But it 
causes conjunctival hyperemia, periocular pigmentation, hypertrichosis, 
iris hyperpigmentation. It is also known as prostaglandin related 
periorbitopathy13. 
LASER TREATMENT: 
Laser procedures are, 
Laser Trabeculoplasty, 
Laser Iridotomy, 
Laser Iridoplasty, 
Cyclophotocoagulation. 
1. LASER TRABECULOPLASTY: 
     It can be 
• Argon Laser Trabeculoplasty 
• Selective Laser Trabeculoplasty 
• Micropulse Laser Trabeculoplasty. 
 INDICATIONS 
• Pseudo exfoliation glaucoma, 
• Pigmentary glaucoma, 
• Chronic open angle glaucoma. 
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ARGON LASER TRABECULOPLASTY: 
• It uses power of 300- 1200 mW, 
• spot size is 50 µm, 
• 180 degrees of trabecular meshwork can be treated 
simultaneously. 
• 30-50 spots applied. 
       End point is transient blanching to bubble formation. 
Complications of Argon Laser Trabeculoplasty are scarring of 
trabecular area, eventually resulting in failure of trabeculoplasty. 
SELECTIVE LASER TRABECULOPLASTY: 
In this procedure, frequency doubled ND: YAG laser is used. It 
selectively targets pigmented trabecular meshwork, without damaging 
nonpigmented trabecular meshwork. 
• The spot size is 400 microns 
•  Frequency of laser is 532 nm, 
•  Power is 0.8 mJ 
•  Duration is 3 nano sec, 
• 50 spots are applied, 
• 180-360 degree can be treated simultaneously. 
The main advantage over argon laser trabeculoplasty is, it is a 
repeatable procedure. There is no scarring. 
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 MICROPULSE LASER TRABCULOPLASTY: 
This technology breaks the continuous wave into short pulses, 
that allow cooling. So it reduces thermal damage. 
• It uses 532 nm wavelength 
• power is 1000 mW, 
• spot size 300 µm, 
• 15% duty cycle, 
• 360º can be treated simultaneously. 
COMPLICATIONS: 
     It includes 
• Transient IOP spikes, 
• Iritis, 
• Inadvertent damage to cornea, lens, fovea. 
• Hemorrhage. 
But laser trabeculoplasty is contraindicated in angle closure and 
uveitic glaucoma. 
LASER IRIDOTOMY: 
• It is indicated in angle closure suspects, angle closure 
glaucoma, creeping angle closure glaucoma. 
• Laser used is ND: YAG, 
•  Lens used are Abraham lens and Wise lens. 
•  Placement of laser- superior iris 11-1 o'clock. 
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•  Patient should be instructed to apply pilocarpine drops to 
stretch iris. 
LASER IRIDOPLASTY: 
       It is most commonly done in pleateau iris syndrome. 
OTHER LASER PROCEDURES: 
• Co2 Laser assisted Sclerectomy Surgery, 
• Laser Suturelysis 
• Laser Synechiolysis, 
• Gonio Photocoagulation 
• Goniopuncture. 
SURGICAL PROCEDURES: 
 The filtration procedures includes, 
• External filtration surgeries, 
• Internal filtration surgeries. 
 EXTERNAL FILTERING SURGERY: 
       It can be further classified as, 
• Full thickness procedures, 
• Partial thickness procedures. 
Trabeculectomy was first introduced by Cairns in1968. It creates 
fistula at limbus, so that there is a direct communication between 
anterior chamber and subconjunctival space. It bypasses trabecular 
meshwork and schlemm's canal. 
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 INDICATION: 
• Rapid progression of field defects, 
• Medically uncontrolled glaucoma, 
• Poor compliance with medical therapy, 
• Intolerance to medical therapy due to side effects of 
antiglaucoma drugs11. 
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STEPS OF TRABECULECTOMY PROCEDURE: 
ANASTHESIA: 
It is by retrobulbar, peribulbar, subtenon, subconjunctival 
anasthesia. 
In paediatric cases, general anasthesia is preferred. 
SUPERIOR RECTUS BRIDLE SUTURE, 
CONJUNCTIVAL FLAP: 
It has 2 types 
• Limbal based conjunctival flap, 
• Fornix based flap. 
CHARACTERISTICS OF LIMBAL BASSED FLAP: 
• Difficult to perform, 
• Exposure is not good 
• Difficult to make releasable sutures, 
• Conjunctival handling is comparatively high, 
• Antimetabolite application is relatively easy, 
• Bleb appearance is ring of steel. 
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Figure 16: Conjunctival flaps 
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CHARACTERISTICS OF FORNIX BASSED FLAP: 
• This flap creation can be easily performed, 
• Exposure will be adequate. 
• Antimetabolites application needs great caution as it causes 
necrosis of adjacent tissues. 
• But conjunctival handling will be less, scarring is less, possibility 
of re operation is there. 
• Bleb appearance will be posteriorly draining diffuse bleb. 
SCLERAL FLAP DISSECTION: 
• Partial thickness scleral flap, either triangular or rectangular in 
shape. 
CONTROLLED PARACENTESIS: 
• It is the very essential step, as it prevents sudden drop in IOP, 
thereby preventing hypotonic maculopathy, 
• Also it is used for AC formation, 
• continuous IOP maintenance by irrigation with saline or 
viscoelastic substance2. 
SCLEROSTOMY: 
• It is done with kelly's punch or manually removed. 
PERIPHERAL IRIDECTOMY; 
• It should be typically a wider PI, extending beyond sclerostomy 
margins. 
• So it prevents incarceration of iris pillars into sclerostomy site. 
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CLOSURE OF WOUND: 
• Scleral flap suturing with 10-0 nylon sutures. It can be either 
• Fixed sutures, 
• Adjustable sutures, 
• Releasable sutures. 
LASER SUTURE LYSIS: 
It is done to enhance filtration, done within 3 weeks, 
• If anti metabolites are used, it can be done within 8 weeks. 
• It is done with the help of  
• Hoskins lens, 
•  blumenthal lens,  
• volk lens, 
• Done with argon laser 
COMPLICATIONS: 
INTRAOPERATIVE: 
• Buttonholing of conjunctiva, 
• scleral flap damage, 
• Hemorrhage, 
• supra choroidal hemorrhage. 
 POST OPERATIVE COMPLICATIONS: 
• HYPOTONY WITH FLAT AC; 
          It occurs due to, 
Bleb leak, 
Over filtration and 
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Choroidal effusion. 
• HYPOTONY WITH DEEP AC: 
It is due to over filtration. 
• ELEVATED IOP WITH FLAT AC: 
It is due to, 
Aqueous misdirection, 
Pupillary block, 
Delayed suprachoroidal hemorrhage 
• ELEVATED IOP WITH DEEP AC: 
It is due to bleb failure by, 
Internal blockade of ostium, 
Encapsulated bleb4. 
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AIM & OBJECTIVES 
Aim 
To clinically analyse the Association of systemic factors in 
primary open angle glaucoma. 
Objectives 
 Incidence of association of systemic factors (diabetes, hyperten-
sion, dyslipidemia, thyroid disorder, anemia, ischemic heart dis-
ease and others)in primary open angle glaucoma. 
 Comparing the progression of Primary Open Angle Glaucoma in 
Patients with systemic factors and without systemic factors 
Subject Selection 
100 patients of primary open angle glaucoma in the age group of 40-
70 years attending glaucoma services at regional institute of ophthalmology 
were included in the study. 
Inclusion criteria 
 Age group 30-70 years 
 IOP>21 mm of Hg 
 Angles more than 270° should be > 3 (schaffers grading) in both 
eyes 
 Patients having Glaucomatous field defect on automated            
perimetry 
Exclusion criteria 
 Age <30 years and >70 years 
 Patients with angle closure 
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 Patients with secondary glaucoma 
Analysis plan 
 Demographic pattern of glaucoma in patients with systemic      
diseases 
 Progression of glaucoma 
 To analyse course of primary open angle glaucoma 
 To analyse the etiology of primary open angle glaucoma 
 To analyse the clinical profile of primary open angle glaucoma 
 Treatment modalities 
 Outcomes following treatment 
Methodology  
All were subjected to detailed anterior segment examination, best 
corrected visual acuity, intraocular pressure measurement either by 
Goldmann applanation tonometry or in cases with presence of corneal 
edema rebound tonometry reading was recorded, fundus examination, 
gonioscopic examination and visual field analysis will be done. Surgical 
procedures like trabeculectomy, antiglaucoma device and laser 
trabeculoplasty were done where necessary 
Follow up 
All patients are monitored regularly every three months to look 
for progression of glaucoma. At each visit visual acuity measurement, 
anterior segment examination by slit lamp, intraocular pressure by 
applanation tonometer, fundus examination and visual field analysis will 
be done. 
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Screening procedures 
 Detailed history of present illness, associated systemic illness 
 Complete general examination of the patient and vitals            
measurement 
 Visual acuity using Snellen’s acuity chart 
 Complete examination of anterior segment and posterior segment 
 Intraocular pressure measurement 
 Direct and Indirect ophthalmoscopy 
 Fields 
 Random blood sugar, Blood Pressure 
 Lipid profile 
 Thyroid profile 
 Complete hemogram 
 ECG, Echo cardiogram 
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OBSERVATION AND ANALYSIS: 
200 eyes of 100 patients with intraocular pressure more than 21 
mmhg on all occasions were taken for the study. 
AGE DISTRIBUTION: 
 
 
 
 
 
 
 
 
 
The ages of patients in our study varied from 40-70 years. Among 
100 patients, 31 patients were between 40-49 years, 32 patients were in 
the age group of 50-59 years, 37 patients were in the age group of > 60 
years. So the average age incidence is around 50-60 years. The possible 
reason for this age incidence is that most of this age group patients visit 
to hospital for refractive error or cataractous changes. Primary open 
angle glaucoma is detected by intraocular pressure measurement and 
fundus examination as part of routine examination. 
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Chart 1 showing Age distribution 
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Female
44%
Male
56%
SEX DISTRIBUTION:  
 
 
 
 
 
 
 
 
In this study, 56% were males and 44% were females.  
This could be due to high awareness regarding eye diseases and 
their need for refraction correction for their daily work purpose. Hence 
in our country, detection of glaucoma in males is more possible. 
  
Chart 2 showing Sex distribution 
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VISUAL ACUITY DISTRIBUTION: 
 
147 eyes (73.5%) were presented with visual acuity of 6/36 or 
better. 52 eyes (26%)were having 6/36, 35eyes (17.5%) were having 
6/24, 30eyes (15%) were having 6/18, 30eyes (15%) were having 6/12. 
53 eyes (26.5%) were presented with visual acuity of 6/60 or 
worse. The defective vision was due to refractive error in 12 eyes (22%), 
cataractous changes in 23eyes (44%), posterior capsular opacity in 2 
eyes (4%) and due to glaucomatous optic atrophy in 16 eyes (30%). The 
defective visual acuity could be the reason for the need of these patients 
to visit hospital. 
  
Chart 3 showing Visual acuity distribution 
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INTRAOCULAR PRESSURE DISTRIBUTION: 
 
 
 
In this study, out of 200 eyes, 38eyes (19%) presented with IOP 
in the range of 20-25 mmhg. 90eyes (45%) were in the range of 25-30 
mmhg. 37eyes (18.5%) were in the range of 31-35 mmhg. 31 eyes 
(15.5%) were had 36-40 mmhg. 4 eyes (2%) had >40 mmhg.            
So the mean intraocular pressure was 30mmhg. 
  
Chart 4 showing IOP distribution 
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CUP DISC RATIO DISTRIBUTION: 
 
 
In this study, on fundus examination, 
23 eyes (11.5%) had CDR of 0.9,  
34 eyes (17%) had cup disc ratio of 0.8,  
47 eyes (23.5%) had CDR of 0.7,  
 56eyes(28%) had CDR OF 0.6,  
33eyes (16.5%) had CDR of 0.5.  
7eyes (3.5%) had CDR of 0.4. 
In this study, 57 eyes (28.5%) were having advanced cupping (0.8 – 0.9) 
  
Chart 5 showing CDR distribution 
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FUNDUS 
 
 
 
 
 
 
 
  
FUNDUS CHANGES PERCENTAGE OF EYES 
NO OF 
EYES 
NASALISATION OF VESSELS 62.00% 124 
BAYONETTING OF VESSELS 56.00% 112 
LAMINOR DOT SIGN 66.00% 132 
BARRING OF CIRCUMLINEAR 
VESSELS 22.00% 44 
FOCAL NOTCHING 58.00% 116 
PARAPAPILLARY ATROPHY 28.00% 56 
RNFL DEFECTS 3.00% 6 
Table 1 showing Fundus findings 
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VISUAL FIELD DEFECTS DISTRIBUTION:  
 
 
In our study, 140 eyes (70%) were presented with visual field 
defects in both superior and inferior arcuate regions. This is because of 
the fact that most patients were presented in the advanced stage of the 
disease. 6 eyes (3%) had nasal step, 3 eyes (1.5%) had paracentral field 
defects, 10 eyes (5%) had tubular field. Fields were not possible in 14 
eyes (7.5%) due to poor vision. 
– The absolute field defects were more than relative field defects. 
This also indicates the advanced stage of presentation. 
 
  
  
Chart 6 showing Field defects distribution 
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DISTRIBUTION OF HYPERTENSION: 
CATEGORY SYSTOLIC (mmhg) DIASTOLIC (mmhg) 
NORMAL < 120 < 80 
PREHYPERTENSION 120- 139 80-89 
HYPERTENSION >140 >90 
 
 
 
 
 
  
Chart 7  showing Distribution of Hypertension 
Table 2 showing categories of hypertension 
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In this study, out of 100 patients, 25 patients (25%) were in 
prehypertensive stage. 47 patients (47%) had hypertension. 
 NO OF PATIENTS PERCENTAGE 
NORMAL 28 28 
PHT 25 25 
HT 47 47 
TOTAL 100 100 
 
 
 
SEVERITY OF GLAUCOMA  IN HYPERTENSIVES 
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Table 3 showing Distribution of Hypertension 
Chart 8  showing  HT & IOP correlation 
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IOP CORRELATION WITH HYPERTENSION 
 
IOP N PHT HT 
20-25 22 13 3 
26-30 28 32 30 
31-35 4 2 31 
36-40 2 3 26 
41-45 0 0 4 
 
 
In our study, patients without hypertension group had IOP range 
of 20-30 mmhg. Prehypertensive group had predominantly presented 
with the IOP range of 26-30 mmhg. 
In Hypertensive group, 30% eyes had IOP range of 26-30mmhg. 
31% had presented with IOP range of 31-35 mmhg. 26% had presented 
with iop range of 36-40 mmhg. 4% eyes had IOP range of >40 mmhg.  
This observation is statistically significant with p value of 
0.000, by chi square analysis. 
 
 
 
 
 
 
 
Table 4 showing distribution of IOP in hypertension 
patients 
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CDR CORRELATION WITH HYPERTENSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In our study, patients without hypertension group had presented 
mostly with CDR range of 0.6-0.7. prehypertensive group had  
predominantly CDR range of 0.6-0.7.  
In Hypertensive group, 43% eyes had CDR range of 0.8-0.9, 44% 
were having CDR range of 0.6-0.7, 7% eyes had 0.4-0.5. 
This observation is statistically significant with p value of 
0.000 by chi square analysis. 
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Table 5 showing distribution of CDR in 
hypertensives 
Chart 9 showing distribution of CDR in hypertensive patients 
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DISTRIBUTION OF DIABETES:           
 
 
 
 
 
 
 
 
 
 
  
Chart10 showing Distribution of Diabetes. 
Table 6 showing categories of diabetes 
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NO OF 
PATIENTS 
PERCENTAGE 
NORMAL 44 44 
PREDIABETTIC 17 17 
DIABETIC 39 39 
TOTAL 200 100 
 
 
In this study, out of 100 patients,  
 
34 patients (17%) were in prediabetic stage, 
39 patients (39%) were having diabetes. 
 
IOP Correlation with Diabetes Mellitus 
 
IOP N PDM DM 
20-25 21 9 8 
26-30 45 15 30 
31-35 12 4 21 
36-40 9 6 16 
41-45 1 0 3 
 
 
 
Table 6 showing Distribution of Diabetes. 
Table 8 showing distribution of IOP in Diabetes. 
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In this study, patients without diabetes group (88%),most of the 
patients(66%) were presented with the IOP range of 20-30 mmhg. 
  Prediabetic group (36%), most of the patients (26%) were in the 
IOP range of 26-30 mmhg. 
In diabetic group (78%), 38% were having below 30mmhg. 40% 
were having > 30 mmhg. 
This observation is statistically significant with p value of 
0.031, by chi square analysis. 
 
 
Chart 11 showing distribution of IOP in Diabetes 
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CDR CORRELATION WITH DIABETES MELLITUS 
CDR N PDM DM 
0.4-0.5 22 8 10 
0.6-0.7 50 18 35 
0.8-0.9 16 8 33 
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Chart 12  showing distribution of CDR in diabetes. 
Table 9 showing distribution of CDR in diabetes 
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In patients without diabetes group, most of the patients (50%) 
were having CDR of 0.6-0.7. 
In prediabetic group, 18% were having CDR of 0.6-0.7. 
In diabetic group, 35% were having CDR of0.6-0.7, 33% were 
having CDR of 0.8-0.9. 
This observation is statistically significant with p value of 
0.031 by chi square analysis. 
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GLAUCOMA AND CHOLESTEROL  ASSOCIATION 
DISTRIBUTION OF CHOLESTEROL: 
 
 
 NUMBER OF PATIENTS PERCENTAGE 
NORMAL 53 53 
BODERLINE 23 23 
HIGH 24 24 
  
 
In this study, out of 100 patients 23 patients (23%) were having 
high cholesterol levels,  
24 patients (24%) were having borderline cholesterol levels. 
  
 
NORMAL 
mg/dl 
BODERLINE 
mg/dl 
 
HIGH 
mg/dl 
CHOLESTEROL < 200 200-239 >240 
TRIGLYCERIDES <150 150-199 >200 
LDL 60 35-59 <35 
HDL 60-130 130-159 >160 
Table 10 showing distribution of Cholesterol 
Table 10 showing categories of Cholesterol 
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CORRELATION OF CHOLESTEROL WITH IOP: 
IOP N B H 
20-25 21 12 5 
26-30 46 20 24 
31-35 20 7 10 
36-40 15 7 9 
41-45 4 0 0 
 
 
 
 
 
IOP & DYSLIPIDEMIA 
 
 
 
 
 
 
Chart 13 showing correlation of IOP with Cholesterol 
Table 12 showing distribution of IOP in dyslipidemia patients 
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In patients without cholesterol group, maximum percentage 
(86%) were having IOP range of < 35 mmhg. 
In borderline group, 32% were having iop range < 30 mmhg. 
In high cholesterol group, maximum percentage of patients 
(34%) were having IOP range of 25-35 mmhg. 
So in this study, there was no association of cholesterol with IOP. 
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CORRELATION OF CHOLESTEROL WITH CDR: 
 
 
CDR & DYSLIPIDEMIA 
 
 
 
 
 
CDR N B H 
0.4-0.5 22 11 7 
0.6-0.7 46 25 32 
0.8-0.9 38 10 9 
Chart 14 showing distribution of CDR in cholesterol patients 
Table 13 showing distribution of CDR in cholesterol patients 
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In patients with normal cholesterol levels, maximum percentage  
(22%) were having CDR range of 0.4-0.5. 
In patients with borderline cholesterol levels, 43% had CDR 
range of 0.6-0.7, 35% had CDR 0.8 - 0.9. 
In patients with high cholesterol levels, 67% were having CDR 
range of  0.6-0.7, 19% had CDR 0.8 - 0.9. 
This observation is statistically significant with p value of 
0.006 by chi square analysis. 
 
  
 
 
70 
 
MEAN OCULAR PERFUSION PRESSURE AND GLAUCOMA 
    It is calculated by 2/3(mean arterial pressure – IOP). 
Mean arterial pressure is calculated by Diastolic BP + 1/3 
(Systolic BP- Diastolic BP)  
 MEAN OCULAR  PERFUSION PRESSURE DISTRIBUTION: 
 
  
MOPP NO OF EYES 
30-40 39 
41-50 137 
51-60 24 
Table showing Distribution of MOPP 
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MOPP WITH IOP CORRELATION: 
 
 
 
 
 
 
  
MOPP 20-30 31-40 >40 
30-40 18 17 4 
41-50 87 50 - 
51-60 23 1 - 
Chart 15 showing correlation of IOP & MOPP 
Table 15 showing correlation of IOP & MOPP 
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In this study, MOPP 30-40 mmhg group, out of 39 eyes, 18 
eyes(46%) had  IOP within 20-30 mmhg, 17 eyes(43%) had IOP range 
of 31-40 mmhg, 4(10%) eyes had IOP > 40 mmhg. 
In MOPP 41-50 mmhg group, 87 eyes(63%)  had IOP range of 
20-30 mmhg, 50 eyes(36%) had IOP range of 31-40mmhg. 
In MOPP 51-60 mmhg, 23 eyes(95%)  had IOP range of 20-30 
mmhg, 1eye(4%)  had iop 31-40 mmhg. 
Thus we observed a negtive correlation between MOPP and IOP.  
This observation is statistically significant with p value 0.000 
by pearson correlation 
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MOPP WITH CDR CORRELATION: 
MOPP 0.4-0.5 0.6-0.7 0.8-0.9 
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41-50 64 36 37 
51-60 19 4 1 
 
 
 
In this study, MOPP 30-40 mmhg group, 51% had CDR 0.6-0.7. 
19 eyes (48%) had CDR 0.8-0.9. 
In MOPP 41-50 mmhg group, 46% had CDR 0.4-0.5, 26% had 
0.6-0.7,  27%  had 0.8-0.9. 
In MOPP 51-60 group, 79%  had CDR 0.4-0.5, 16%  had 0.6-0.7, 
4% had 0.8-0.9. 
Chart 16 showing correlation of MOPP & CDR 
Table 16 showing correlation of MOPP & CDR 
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We found a negative correlation between MOPP and CDR 
progression. This observation is statistically significant with p value 
of 0.000 br pearson analysis 
DISTRIBUTION OF OTHER DISEASES: 
 NO OF PATIENTS PERCENTAGE 
NORMAL 87 87 
ANEMIA 13 13 
 
 
 
 
In this study, out of 100 patients, 13 patients (13%) were having 
anaemia. Hemoglobin level < 12g/dl is defined as anemia. 
  
Table 17  showing distribution of Anemia. 
Chart 17 showing Distribution of Anemia 
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THYROID ASSOCIATION AND GLAUCOMA: 
 
 
 
 
 
 
 
 
 
12 patients (12%) were having hypothyroid. 
 
 
  
 NO OF PATIENTS PERCENTAGE 
NORMAL 88 88 
HYPOTHYROID 12 12 
Table 18 showing distribution of Thyroid disease 
Chart 18 showing distribution of Thyroid 
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ASSOCIATION OF CARDIAC DISEASE AND GLAUCOMA: 
 
 
 
 
 
 
 
 
 
 
 7 patients (7%) were showing changes in ECG, which includes 
left ventricular hypertrophy, coronary heart disease. 
 
  
ECG NO OF PATIENTS PERCENTAGE 
NORMAL 93 93 
ABNORMAL 7 7 
Chart 19 showing distribution of Cardiac disease 
Table 19 showing distribution of Cardiac disease 
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DISTRIBUTION OF SYSTEMIC ASSOCIATIONS: 
 
 
 
 
 
 
 
 
 
 
 
  
Chart 20 showing distribution of Systemic disease 
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RESULTS 
In our study, the commonest age group was between 50-60 years. 
Males are slightly more than the females. 
In this study, 147 eyes (73.5%) presented with visual acuity of 
6/36 or better. 52eyes (26%) presented with visual acuity in the range of 
6/60 to HM. The reason for defective vision was refractive error (22%), 
cataractous lens changes (44%), posterior capsule opacity (3.8%), 
advanced glaucoma damage (30%). 
128 eyes (64%) presented with intraocular pressure in the range 
of 20-30 mmhg. 68eyes (34%) were presented in the range of 30-40 
mmhg. 4eyes (2%) had >40 mmhg. 
104eyes (52%) were presented with CDR 0.7- 0.9, 96 eyes (48%) 
had CDR 0.4-0.6. 
124 eyes (62%) had nasalisation of vessels, 112 eyes (56%) had 
bayonetting of vessels, 132 eyes (66%) had laminar dot sign, 44 eyes 
(22%) had barring of circumlinear vessels, 116 eyes (58%) were 
presented with focal notching, 62 eyes (31%) had parapapillary atrophy 
140eyes (70%) were having both superior and inferior arcuate scotomas. 
10eyes (5%) were presented with tubular field of vision. 
On systemic evaluation, 25 patients (25%) were in 
prehypertension stage. 47patients (47%) were hypertensives.  
Prehypertensives were having IOP range of 26-30mmhg and CDR range 
of 0.6-0.7. Hypertensive group, 61% were having IOP range of 
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>30mmhg, 43% were having CDR range of0.8-0.9,44% were having 
CDR of 0.6-0.7. 
  17 patients (17%) were in prediabetic stage, 39patients (39%) 
were diabetics. Prediabetic group were having IOP range of 26-30 
mmhg and CDR range of 0.6-0.7.  Diabetic group were having IOP 
range of  >30 mmhg, 35% having CDR range of 0.6-0.7 and 33% having 
0.8-0.9. 
23 patients were having cholesterol in the borderline.24 patients 
were having high cholesterol levels. Borderline cholesterol group, most 
of the patients (70%) were having IOP range of <30 mmhg, CDR range 
of 0.6-0.7. High cholesterol group were having IOP range of 25-35 
mmhg, 67% patients were in CDR range of 0.6-0.7, 19% having 0.8-0.9. 
39 patients were having MOPP of <40 mmhg. In this group, 53% 
had IOP>30mmhg. 51% had CDR 0.6-0.7, 48% had CDR 0.8-0.9. 
7 patients (7%) were showing ECG changes which includes left 
ventricular hypertrophy and.13 patients (13%) were anaemic. 12 patients 
(12%) were presented with hypothyroidism. 
         Out of 100 patients, 87 patients had systemic diseases. Among 
them maximum number of patients (47%) had hypertension. The second 
most common systemic disease presented was diabetes (39%). 
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DISCUSSION 
100 patients with primary open angle glaucoma who satisfied the 
eligibility criteria were enrolled for this study. They were evaluated with 
proper history taking, visual acuity examination, anterior segment 
examination by slit lamp, IOP measurement, detailed fundus 
examination, visual field test by automated perimetry. All the patients 
have undergone blood pressure measurement, random blood sugar 
examination, lipid profile, thyroid profile, hemoglobin level, ECG 
changes. 
In this study, the most common age group was 50-70 years. This 
indicates that POAG is a disease of elderly. Males were slightly more 
affected than females. 
In our study, maximum number of patients were presented with 
cup disc ratio of 0.8 – 0.9 and tubular field of vision. This indicates the 
asymptomatic nature of the disease. We also found that maximum 
number of eyes had superior and inferior arcuate scotomas which 
correlated well with the advanced cupping and 5% patients presented 
with tubular field of vision. These were absolute field defects. 
Ocular blood flow is determined by mean ocular perfusion 
pressure. So decrease in perfusion pressure compromises blood flow to 
ocular region, if there is no autoregulation. 
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Hypertension and Diabetes which are microangiopathic diseases 
leading to vascular compromise to optic nerve head leading to 
glaucoma. 
Dyslipidemia causes atherosclerosis of vessels, resulting in 
vascular compromise to optic nerve head. 
cristina leske suggested in their study that low ocular perfusion 
pressure was significantly associated with open angle glaucoma and also 
established a positive correlation between blood pressure and intraocular 
pressure. 
Mitchell, Paul, Lee, Anne et al suggested that poorly controlled 
hypertension is related to increased risk of glaucoma. 
T Sato, S Roy. suggested in their study that aqueous humor of 
diabetic patients show increased glucose which increases fibronectin 
synthesis and accumulation in trabecular cells resulting in failure of 
aqueous outflow facility. They also suggested a common biological link 
between vascular endotheial cells and trabecular cells due to high 
glucose levels. 
Suzana pavljasevic suggeted in their study that dyslipidemia is 
one of the important risk factor in the pathogenesis of POAG. They also 
suggested that hyperlipidemia is highly atherogenic and low antioxidant 
activity. Treatment with statins could reduce the risk of glaucoma 
appearance. 
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CONCLUSION 
This study indicates that there is a significant association between 
primary open angle glaucoma and hypertension, diabetes and 
dyslipidemia. 
There is a negative correlation between mean ocular perfusion 
pressure and severity of glaucoma. 
This study results correlates well with previously done studies in 
systemic factors association in POAG. So this study results highlights 
the role of vascular factors in the pathogenesis of POAG. 
It also emphasizes that all primary open angle glaucoma patients 
should undergo systemic investigations to find out associated 
hypertension, diabetes and hypercholesterolemia thereby preventing the 
further progression of glaucoma. 
This study also indicates the importance of a good interaction 
between ophthalmologist and physician, so that patients showing 
vascular insufficiency and atherosclerosis due to diabetes, hypertension 
and high cholesterol levels should be screened for POAG also. Thereby 
we can diagnose the primary open angle glaucoma at an early stage 
before significant loss of retinal ganglion cells and further blindness can 
also be prevented. 
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CLINICAL STUDY OF ASSOCIATION OF SYSTEMIC 
FACTORS IN PRIMARY OPEN ANGLE GLAUCOMA IN A 
TERTIARY CARE CENTER 
PROFORMA 
CASE NUMBER:  
1. Name:  Age / Sex: Mobile No: 
    OP No/Date:    
   Place:    
2. Symptoms: (Duration)   
   Defective vision Pain                     Redness Photophobia 
Any other symptoms:    
3. Past history -    
History of any intraocularsurgery / trauma / Laser 
4. Medical history –  
Diabetes / hypertension / IHD / vaso occlusive disease / bronchial asthma / 
chronic disease / steroid usage (long term)/ Dyslipidemia/ Anemia 
5. Family history-  
History of diabetes / hypertension / ischemic heart disease / vein occlusion 
diseases in the family  
6. Ocular Examination: 
Vision: (BCVA) 
        RE: LE: 
Tension: 
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        GAT/Rebound tonometry: RE:         mmhg LE: mmhg 
 
 
Gonioscopy: schaffer RE                                              LE  
Fundus : RE: media:                         disc and vessels: 
LE: media:                          disc and vessels: 
7. Other Investigations: 
8. Diagnosis: 
9.Treatment Plan: 
       Medical: Topical drugs    
       Surgical: Trabeculectomy / anti glaucoma device / Laser    
trabeculoplasty 
 
10. Follow up:                                               Monthly Visits 
 RE LE 
Lids   
Conjunctiva   
Cornea   
Anterior chamber: 
Depth 
Cells/flare   
Iris   
Pupil: 
Size shape reaction   
Lens : 
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Visual acuity 
Anterior segment 
Fundus 
IOP 
Gonioscopy 
Fields 
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KEY TO MASTER CHART 
IP/NO  - INPATIENT NUMBER 
CDR  - CUP DISC RATIO 
IOP  - INTRAOCULAR PRESSURE 
AP  - AUTOMATED PERIMETRY 
RE  - RIGHT EYE 
LE  - LEFT EYE 
A  - ABSOLUTE DEFECT 
R  - RELATIVE DEFECT 
S  - SUPERIOR ARCUATE AREA 
I  - INFERIOR ARCUATE AREA 
NS  - NASAL STEP 
PC  - PARACENTRAL 
TUB  - CENTRAL TUBULAR FIELD OF VISION 
NP  - NOT POSSIBLE 
HT  - HYPERTENSION 
PHT  - PREHYPERTENSION 
DM  - DIABETES 
PDM  - PREDIABETIC 
N  - NORMAL 
B  - BORDER LINE 
H  - HIGH 
A  - ANEMIA 
HYPO - HYPOTHYROID 
AB  - ABNORMAL 
MOPP - MEAN OCULAR PERFUSION PRESSURE 
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MASTER CHART 
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